CPH 0.00% 0.9¢ creso pharma limited

Ann: Creso Reports Strong Financial Performance in FY22, page-8

  1. 4,269 Posts.
    lightbulb Created with Sketch. 689
    What a circus. So many things that holders should be deeply concerned about, but this soundbite from the first page really sums up CPH's attitude to retail investors over the last 5 or so years...IMHO

    "The Company made several changes to increase the quality and independence of its board, resulting in an increase in independence from 0% at the beginning of FY22"

    How on earth can a company with no board independence be allowed to trade on the ASX?
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.